These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 1369724)

  • 1. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
    Mohler ER; Hiatt WR; Creager MA
    Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
    Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP; Anthony R; Cobb FR; Koda I; Jiao J; Hiatt WR
    J Am Coll Cardiol; 2006 Dec; 48(12):2539-45. PubMed ID: 17174195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    ; Leizorovicz A; Becker F
    Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S; Bach R; Schieffer H
    Int Angiol; 1992; 11(3):204-10. PubMed ID: 1460355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
    Regensteiner JG; Stewart KJ
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):604-10. PubMed ID: 17063165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U; Amberger HG; Böhme H; Diehm C; Dimroth H; Heidrich H; Heinrich F; Hirche H; Mörl H; Müller-Bühl U
    Dtsch Med Wochenschr; 1984 May; 109(19):745-50. PubMed ID: 6373217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostanoids in therapy of peripheral arterial occlusive disease.
    Creutzig A; Caspary L
    Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of peripheral arterial disease: a comprehensive review.
    Stoyioglou A; Jaff MR
    J Vasc Interv Radiol; 2004 Nov; 15(11):1197-207. PubMed ID: 15525738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
    Kakkos SK; Geroulakos G; Nicolaides AN
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.